Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 556541 - 556560 out of 557927 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AG) monoclonal antibodies | NIKTIMVO 9MG/0.18ML SINGLE DOSE | 0.18ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | IncyteCorporation |
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 108MG/0.68ML INJ,SOLN,PEN | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 108MG/0.68ML INJ,SOLN,PEN | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 300MG/20ML INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 300MG/20ML INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L04AG10) inebilizumab | UPLIZNA | 3X10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuromyelitis Optica | AmgenUSA,Inc. |
| USA | (L04AG10) inebilizumab | UPLIZNA | 3X10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuromyelitis Optica | AmgenUSA,Inc. |
| USA | (L04AG11) anifrolumab (adm: P, previous atc code l04aa51. new atc 4th level l04ag valid from january 2024.) | SAPHNELO 120MG/0.8ML INJ,SOLN,PEN | 0.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L04AG11) anifrolumab (adm: P, previous atc code l04aa51. new atc 4th level l04ag valid from january 2024.) | SAPHNELO 120MG/0.8ML INJ,SOLN,SYRINGE | 0.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L04AG12) ofatumumab (adm: P) | KESIMPTA 20MG/0.4ML PEN INJ (SENSOREADY) | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisPharmaceuticalsCorporation |
| USA | (L04AG12) ofatumumab (adm: P) | KESIMPTA 20MG/0.4ML PEN INJ (SENSOREADY) | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisPharmaceuticalsCorporation |
| USA | (L04AG13) teprotumumab | TEPEZZA 500MG VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graves Ophthalmopathy | AmgenUSA,Inc. |
| USA | (L04AG13) teprotumumab | TEPEZZA 500MG VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Graves Ophthalmopathy | AmgenUSA,Inc. |
| USA | (L04AJ01) eculizumab (adm: P) | BKEMV 10MG/ML INJ,SOLN | 30ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AmgenUSA,Inc. |
| USA | (L04AJ01) eculizumab (adm: P) | BKEMV 10MG/ML INJ,SOLN | 30ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AmgenUSA,Inc. |
| USA | (L04AJ04) sutimlimab (adm: P) | ENJAYMO 50MG/ML INJ | 22ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemolysis;Anemia, Hemolytic, Autoimmune | RecordatiRareDiseases,Inc. |
| USA | (L04AJ04) sutimlimab (adm: P) | ENJAYMO 50MG/ML INJ | 22ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemolysis;Anemia, Hemolytic, Autoimmune | RecordatiRareDiseases,Inc. |
| USA | (L04AJ04) sutimlimab (adm: P) | ENJAYMO 50MG/ML INJ | 22ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemolysis;Anemia, Hemolytic, Autoimmune | RecordatiRareDiseases,Inc. |
| USA | (L04AJ04) sutimlimab (adm: P) | ENJAYMO 50MG/ML INJ | 22ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hemolysis;Anemia, Hemolytic, Autoimmune | RecordatiRareDiseases,Inc. |
| USA | (L04AJ05) avacopan (adm: O) | TAVNEOS 10MG CAPSULE | 180 | Ex-factory price without vat |
$0-0 |
$0-0 |
Microscopic Polyangiitis;Wegener Granulomatosis | AmgenUSA,Inc. |
Pages
